BME (BME) Stock Price & Analysis
BME (BME) rose 1.01% to USD 42.85 as of July 25, 2026 at 02:25 UTC, according to Nexqual real-time market data.
BME last closed at USD 42.42; the session ranged USD 42.63–43.2 on volume of 46,226 shares. Market capitalization is —, with a 52-week range of USD 35.03–44.35 (NYQ). Source: Nexqual, July 25, 2026 at 02:25 UTC.
Key Statistics (as of July 25, 2026 at 02:25 UTC)
| Price | USD 42.85 |
|---|---|
| Change | ▲ 1.01% (up) |
| Previous Close | USD 42.42 |
| Open | USD 42.88 |
| Day Range | USD 42.63 – 43.2 |
| 52-Week Range | USD 35.03 – 44.35 |
| Volume | 46,226 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (BME)
Nexqual's technical model rates BME "BUY" based on 4 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 02:25 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 59.72 (neutral) |
| vs SMA50 | Above (USD 41.11) |
| MACD | 0.38 (positive) |
Analyst Ratings (BME)
Wall Street analysts rate BME "None", per Nexqual as of July 25, 2026 at 02:25 UTC.
| Consensus Rating | None |
|---|
Earnings (BME)
Source: Nexqual, July 25, 2026 at 02:25 UTC.
Financials & Fundamentals (BME)
| Total Revenue | $7.74M |
|---|---|
| Revenue Growth (YoY) | +7.60% |
| Gross Margin | +100.00% |
| Operating Margin | +20.25% |
| Profit Margin | +994.98% |
| ROE | +13.81% |
| Debt / Equity | 0.16 |
| Current Ratio | 0.23 |
| Total Cash | $548 |
| Total Debt | $894,332 |
| Free Cash Flow | $-1.96M |
Source: Nexqual, July 25, 2026 at 02:25 UTC.
Financial Health Score (BME)
Nexqual rates BME's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 02:25 UTC.
| Growth | Solid — Revenue +8% YoY (latest Q) |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Solid — $548 cash, no debt |
| Cash Flow | Weak — FCF negative: -$2M, burning cash |
| Efficiency | Mixed — ROE 14%, ROA 0.2% |
Ownership (BME)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +20.41% |
| Short % of Float | +0.47% |
Source: Nexqual, July 25, 2026 at 02:25 UTC.
Major Backers & Investors (BME)
Notable institutional backers of BME include Morgan Stanley, Bank of America Corporation, Invesco, according to Nexqual as of July 25, 2026 at 02:25 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Morgan Stanley | 2.77% |
| Bank of America Corporation | 2.06% |
| Invesco | 1.96% |
| 1607 Capital Partners, LLC | 1.8% |
| Royal Bank of Canada | 1.24% |
| Wells Fargo & Company | 1.18% |
| Karpus Management, Inc. | 1.09% |
| Nova R Wealth, Inc. | 1.09% |
Source: Nexqual, July 25, 2026 at 02:25 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BST | BlackRock Science and Technolog | USD 45.35 | ▼ 1.97% |
| BUI | BlackRock Utility, Infrastructu | USD 27.87 | ▲ 0.8% |
| BGR | BlackRock Energy and Resources | USD 16.5 | ▲ 0.55% |
| CII | BlackRock Enhanced Large Cap Co | USD 24.48 | ▼ 1.13% |
| BMEZ | BlackRock Health Sciences Trust | USD 15.31 | ▲ 1.12% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:25 UTC. This page is informational and not investment advice.